Utepreva LLC is a women’s health company working to close one of the most urgent gaps in cancer care: the lack of a standardized approach for routine early detection of uterine cancer. 

Uterine cancer represents the most common gynecologic malignancy in the United States, with endometrial cancer accounting for the majority of cases, yet clinicians still lack a reliable, routine path to detect it early. We can change that. Our mission is to save lives by modernizing office-based endometrial tissue and fluid sampling and aiding clinicians in the detection of pre-cancer, when treatment is less invasive, and survival outcomes are significantly improved.

Utepreva is a patented, FDA 510(k)-cleared, single-use endometrial sampler designed to collect more tissue while improving patient comfort, helping providers obtain high-quality samples, reach answers faster, and support pre-cancer detection.

Utepreva

Org chart

Teams

Offices